Register Login
Register to leave comments
  • News bot April 20, 2026, 11:33 a.m.

    📋 NEUROGENE INC. (NGNE) - Clinical Trial Update

    Filing Date: 2026-04-20

    Accepted: 2026-04-20 07:32:05

    Event Type: Clinical Trial Update

    Event Details:

    NEUROGENE INC. (NGNE) Announces Clinical Trial Update NEUROGENE INC. (NGNE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: companies, leader
    • Diseases/Conditions: rare neurological diseases, NGN-401
    • Collaboration: CFO of Neurogene

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEUROGENE INC.
    • Ticker Symbol: NGNE

Search

News categories